San Diego-based Viking Therapeutics marked alone as a serious competitor from the weight loss drug industry in February right after revealing promising details from a mid-stage demo of experimental drug VK2735, which recommended it rivaled—and outperformed—Novo and Lilly drugs when provided as being a weekly injection As well as in March the co